Class 4 Medicines Defect Information – Caution in use – Oxylan prolonged-release tablets

27th February 2020

Ref: EL (20)A/12

27 February 2020

Oxylan prolonged-release tablets 10mg — PL 21597/0062

Oxylan prolonged-release tablets 20mg PL 21597/0063

Oxylan prolonged-release tablets 40mg PL 21597/0064

Oxylan prolonged-release tablets 80mg PL 21597/0065

(Manufactured by G.L. Pharma GmbH T/A Healthcare Pharma Ltd)

A class 4 medicines defect alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for missing safety information within the text of the Patient Information Leaflet for specific batches of Oxylan (oxycodone) prolonged-release tablets.

Oxylan prolonged-release tablets 10mg

Batch Number Expiry Date Pack Size First Distributed
9F115A May 2024 56 16th January 2020
9F116A May 2024 56 16th January 2020

 

Oxylan prolonged-release tablets 20mg

Batch Number Expiry Date Pack Size First Distributed
9J114A August 2024 56 16th  January 2020

 

Oxylan prolonged-release tablets 40mg

Batch Number Expiry Date Pack Size First Distributed
9F119A May 2024 56 16th  January 2020

 

Oxylan prolonged-release tablets 80mg

Batch Number Expiry Date Pack Size First Distributed
9F120A May 2024 56 16th  January 2020

 

Further information can be found on MHRA section of the GOV.UK website.

Produced by the NPA Pharmacy Services team February 2020